Phibro Animal Health (PAHC) EBT Margin (2012 - 2026)

Phibro Animal Health's (PAHC) quarterly EBT Margin came in at 8.42% in Q1 2026, down 11.0% year-on-year from 9.47% in Q1 2025, and down 13.52% quarter-over-quarter from 9.74% in Q4 2025.

Phibro Animal Health (PAHC) EBT Margin (2012 - 2026) Analysis & Trends

Phibro Animal Health's EBT Margin history runs 15 years deep, the most recent figure standing at 8.42% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 11.0% year-over-year to 8.42% in Q1 2026; TTM through Mar 2026 was 8.59%, a 718.0% increase from a year earlier, with the FY2025 full-year figure at 5.25%, up 749.0% from the prior year.
  • EBT Margin declined to 8.42% in Q1 2026 per PAHC's latest filing, from 9.74% in the prior quarter.
  • Across five years, EBT Margin topped out at 11.2% in Q1 2022 and bottomed at 10.0% in Q2 2024.
  • The 5-year median for EBT Margin is 4.95% (2022), against an average of 4.54%.
  • Across the five-year window, EBT Margin sank 1841 bps in 2024 and jumped 1630 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 4.95% in 2022, then plunged by 71 bps to 1.43% in 2023, then gained by 10 bps to 1.56% in 2024, then soared by 523 bps to 9.74% in 2025, then declined by 14 bps to 8.42% in 2026.
  • Per Business Quant, the three latest PAHC EBT Margin figures stand at 8.42% (Q1 2026), 9.74% (Q4 2025), and 9.97% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn 8.42%

Historic Data

Download Data
DateValue
Mar 31, 2026 8.42%
Dec 31, 2025 9.74%
Sep 30, 2025 9.97%
Jun 30, 2025 6.30%
Mar 31, 2025 8.54%
Dec 31, 2024 1.56%
Sep 30, 2024 3.69%
Jun 30, 2024 -10.00%
Mar 31, 2024 4.91%
Dec 31, 2023 1.43%
Sep 30, 2023 -5.18%
Jun 30, 2023 8.41%
Mar 31, 2023 6.15%
Dec 31, 2022 4.95%
Sep 30, 2022 2.33%
Jun 30, 2022 4.85%
Mar 31, 2022 11.20%
Dec 31, 2021 10.11%
Sep 30, 2021 4.47%
Jun 30, 2021 7.32%